[1]
2019. Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A series of cases. Revista Alergia México. 66, 3 (Jun. 2019), 282–291. DOI:https://doi.org/10.29262/ram.v66i3.401.